MPST expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.550000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.952800E-01
Normal-vs-Stage2
3.220800E-01
Normal-vs-Stage3
6.465800E-01
Normal-vs-Stage4
2.417600E-01
Stage1-vs-Stage2
7.878200E-01
Stage1-vs-Stage3
8.988400E-01
Stage1-vs-Stage4
3.577600E-01
Stage2-vs-Stage3
6.922200E-01
Stage2-vs-Stage4
2.277600E-01
Stage3-vs-Stage4
4.038000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.486200E-01
Normal-vs-AfricanAmerican
3.258600E-01
Normal-vs-Asian
1.975440E-01
Caucasian-vs-AfricanAmerican
2.143400E-01
Caucasian-vs-Asian
7.940400E-02
AfricanAmerican-vs-Asian
4.336800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.990200E-01
Normal-vs-Female
3.273000E-01
Male-vs-Female
6.569800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.692800E-01
Normal-vs-Age(41-60Yrs)
4.517000E-01
Normal-vs-Age(61-80Yrs)
3.445400E-01
Normal-vs-Age(81-100Yrs)
1.639640E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.238200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.620000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.016000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.530400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.952000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.936800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.029440E-01
Normal-vs-Daily Drinker
3.710800E-01
Normal-vs-Weekly Drinker
2.971000E-01
Normal-vs-Occasional Drinker
4.883800E-01
Normal-vs-Social Drinker
3.740000E-01
Non Drinker-vs-Daily Drinker
4.023200E-01
Non Drinker-vs-Weekly Drinker
3.773800E-01
Non Drinker-vs-Occasional Drinker
8.948400E-01
Non Drinker-vs-Social Drinker
2.225800E-01
Daily Drinker-vs-Weekly Drinker
2.309400E-01
Daily Drinker-vs-Occasional Drinker
7.390800E-01
Daily Drinker-vs-Social Drinker
7.649000E-01
Weekly Drinker-vs-Occasional Drinker
4.014800E-01
Weekly Drinker-vs-Social Drinker
1.742210E-01
Occasional Drinker-vs-Social Drinker
5.871000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.480200E-01
Normal-vs-Grade 2
5.695000E-01
Normal-vs-Grade 3
6.910800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.563600E-01
Grade 1-vs-Grade 3
5.775200E-01
Grade 1-vs-Grade 4
9.480200E-01
Grade 2-vs-Grade 3
3.187800E-01
Grade 2-vs-Grade 4
5.695000E-01
Grade 3-vs-Grade 4
6.910800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.141400E-01
Normal-vs-NonDiabetic
2.989400E-01
Diabetic-vs-NonDiabetic
1.610810E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.308000E-02
Normal-vs-NoPancreatitis
3.674200E-01
Pancreatitis-vs-NoPancreatitis
6.438400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.359200E-01
Normal-vs-N1
3.374800E-01
N0-vs-N1
6.095400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.612190E-01
Normal-vs-TP53-NonMutant
4.770600E-01
TP53-Mutant-vs-TP53-NonMutant
5.748500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
